Skip to main content
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

Market Access Director-for-Hire for MedTech companies

Many MedTech companies reach a stage where occasional market access support is no longer enough, while building a full-time senior function may still be premature, costly, or complex. Market Access Director-for-Hire offers a practical middle ground through flexible, part-time senior leadership. 

MTRC is introducing this model in collaboration with Markus Siebert, Partner of MTRC and Head of Metis Market Access Consulting. It supports companies preparing for a European launch, strengthening their market access function, prioritizing countries and access pathways, and translating reimbursement, HTA, payer, evidence, or health economic findings into internal decisions. 

The model is designed to help companies move from analysis to decisions, and from decisions to tangible progress. Typical support includes reviewing access plans, guiding internal teams, preparing for senior management or board-level discussions, coaching junior or newly formed market access teams, and maintaining strategic momentum during launch or implementation. 

Markus brings more than 25 years of international medical technology market access experience. The service is intended exclusively for MedTech companies and is not offered to consulting firms, academic groups, or pharmaceutical companies. Contact Markus at [email protected] to arrange a short introductory discussion.